STAT: Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine

STAT reports:
HEAVY hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products.
But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by …

The post STAT: Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine appeared first on The Loadstar.

Source: The Loadstar

Be the first to comment on "STAT: Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine"

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

*